Researchers from the University of California, Los Angeles, have developed a technology that delivers a combination therapy to #pancreatic #tumors using #nanoscale particles loaded with irinotecan, a #chemotherapy drug approved as part of a drug regimen for #PancreaticCancer, and an investigational drug that can boost #immune activity and help overcome tumors' resistance. The research team showed that the combination therapy outperformed the sum of its parts in a mouse model of pancreatic cancer.
An official website of the United States government.